A SENSITIVE, COUPLED ASSAY FOR PLASMINOGEN ACTIVATOR USING A THIOL ESTER SUBSTRATE FOR PLASMIN * by Coleman, Patrick L. & Green, George D. J.
A SENSITIVE, COUPLED ASSAY FOR 
PLASMINOGEN ACTIVATOR USING A 
THIOL ESTER SUBSTRATE FOR PLASMIN* 
Patrick L. Coleman and George D. J. Green t 
Department of Human Genetics 
University of Michigan Medical School 
Ann Arbor, Michigan 48109 
t Biology Department 
Brookhaven National Laboratory 
Upton, New York 11973 
INTRODUCTION 
In parallel with the increased interest during the past decade in plasminogen 
activator involvement in fibrinolysis, tumorigenesis, inflammatory responses, and 
the expression of hormonal regulation, there has been a rising interest in sensi- 
tive and precise methods for the specific assay of plasminogen activator. Several 
assays for plasminogen activator employ a direct assay These are 
remarkably sensitive methods, yet they suffer in comparison to the sensitivity 
of coupled Coupling the assay with plasminogen not only amplifies 
the sensitivity by the multiplicative effect of plasmin, but insures that only those 
proteases specific for plasminogen are assayed. The choice of substrate for 
plasmin is critical. In general, esters are superior to amides in both K,,, and 
kcof, but they suffer a major deficiency in that they are frequently unstable at 
pH 7-9, the optimum range for plasmin. Green and Shaws synthesized a 
thiol ester substrate, thiobenzyl benzyloxycarbonyl-L-lysinate (2-Lys-SBzl) , 
which combines high kcat with alkaline stability relative to the commonly used 
esters. 
In an effort to characterize the plasminogen activator from hepatoma tissue 
culture (HTC) and its hormonally controlled inhibitor, several of the known 
direct and coupled methods were found inadequate by reason of either low 
sensitivity or imprecision. Using 2-Lys-SBzl in a coupled approach we have 
developed an assay that is superior to the [1Z51]fibrinolytic assay. It is also 
extremely sensitive to plasminogen activator (-2 X lo-’? moles of urokinase) 
and can be used for routine analysis of purification as well as kinetic and 
binding studies. 
MATERIAL AND METHODS 
Methods 
Plasminogen was prepared from fresh frozen plasma by the method of 
Deutsch and Mertz.9 Purified plasminogen was exhaustively dialyzed against 
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1 mM HCI, lyophilized, and stored at -20°C. Concentration was routinely 
determined by absorbance at 280 nm; E,,,,,,,,l'h = 17.0.1° Plasmin, the gift of 
Dr. David Aronson, was subsequently exhaustively dialyzed against 1 mM HCI 
and stored at -20" C. Plasmin concentration was determined by active-site 
titrations using p-nitrophenyl-p-guanidinobenzoate.ll Urokinase concentration 
was determined by active-site titrations with methylumbelliferyl p-guanidino- 
benzoate.'?. using a ratio fluorometer built by Dr. D. Ballou (Dept. of 
Biological Chemistry). 
Fibrinogen was enzymically iodinated (i using Tris (60 mM) -KCI (300 
mM) buffer, pH 7.6. Unbound iodide was separated by chromatography on 
Dowex 1 (Cl-). Specific radioactivity was 9 X 10l1 cpm/g. Fibrin plates were 
prepared and fibrinolysis continuous assays were performed as previously 
described.6 Discontinuous fibrinolysis assays were also performed, wherein 
plasminogen and urokinase were incubated in the absence of the fibrin, then 
added to the [lZ51]fibrin well. 
Plasminogen activator and inhibitor were prepared from HTC cells as 
previously described I except that serum-free conditioned medium additionally 
contained bovine serum albumin ( 1 mg/ml) . HeLa-cell plasrninogen activator 
was crbtclined i l~  serum-free conditioned itwXurn." 
Assay 
The plasminogen-activator assay is a two-step procedure. In the first step 
plasminogen is activated to plasmin. The plasmin-catalyzed hydrolysis of 
2-Lys-SBzl in the presence of 5,Y-dithiobis (2-nitrobenzoic acid) (DTNB) 
occurs in the second step. All reactions are typically performed in a 24-well 
tissue culture dish (each 15 mm diameter). This is not necessary, but con- 
venient when handling many assays simultaneously. 
The incubation mixture for the first step typically contains: plasminogen, 
1.0 &I; glycine, pH 8.50, 120 mM; bovine serum albumin, 0.5 mg/ml; uro- 
kinase, 2.7 X lo-'* M. Total volume is 50 pl. The activity equivalent in 
plasminogen activator from HTC or HeLa cells may be substituted for uro- 
kinase. The reaction is started by the addition of plasminogen to the otherwise 
complete incubation mixture equilibrated at 37" C. Normally this incubation 
is allowed to react for 45 min. 
The second step is initiated by dilution of the incubation mixture with 
950 pl of the plasmin substrate solution: 2-Lys-SBzl, 200 pM; DTNB 220 pM; 
Triton X-100 0.01 %; sodium phosphate (pH 7.50) 200 mM; sodium chloride, 
200 mM. Normally the second step is quenched after 60 min by the addition 
of 100 pl of soybean trypsin inhibitor ( 1  mg/ml in 1 mM HCI). The ab- 
sorbance at 412 nm may be read immediately or up to 4 h later. The extinction 
coefficient of 14,150 cm-1-M-l was assumed for the thiophenolate product of 
the reaction of benzyl mercaptan with DTNB.15 
Inhibitors were tested by incubation with the first-step incubation mixture 
prior to the addition of plasminogen. Bimolecular rate constants, kam/ [I], were 
determined as previously described.16 Plasmin standard curves were obtained 
by substituting plasmin for plasminogen and urokinase in step one. 
Other variations from the standard procedure were tested. Z-Lys-SBzl was 
substituted by D-Val. Leu. Lys p-nitroanilide. 2,2'-dithiodipyridine and 4,4'- 
dithiodipyridine, dissolved in dimethylformamide, were substituted on an equi- 
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molar basis for DTNB. All absorbance measurements were performed on a 
Gilford spectrophotometer model 2400-2. 
Material 
Fibrinogen (plasminogen-free), urokinase (B grade) and DTNB were the 
products of Calbiochem-Behring (La Jolla, CA) . 2,2’- and 4,4‘dithiodipyridine 
were obtained from Aldrich Chemical Co. (Milwaukee). Carrier-free [lZ5I]- 
(sodium salt) was purchased from Amersham-Searle (Chicago). D-Val. Leu. 
Lys p-nitroanilide was purchased from Kabi Group (Greenwich, CT) . Z-Lys- 
SBzl was synthesized by Peninsula Laboratories (San Carlos, CA) according 
to the procedure of Green and Shaw.8 Methylumbelliferyl p-guanidinobenzoate 
and soybean trypsin iilhibitor ( B  grade) were obtained from Sigma Chemical 
Co. (St. Louis). Phe.Ala.ArgCH,CI was the gift of Dr. Elliott Shaw. All 
other chemicals were of reagent grade; 24-well culture plates were purchased 
from Linbro Co. (Bridgeport, CT) . 
RESULTS 
The sensitivity of the assay depends on the combination of a low “spon- 
taneous” rate of Z-Lys-SBzl hydrolysis with a high enzyme rate. TABLE 1
presents results of a buffer survey in which sodium phosphate yielded both 
the highest plasmin-catalyzed rate and the lowest “spontaneous” rate. The effect 
of Triton X.100 (0.001%-2%) on plasmin activity was determined (data not 
shown). Optimal activity was broadly centered on 0.01 % Triton X-100, which 
was 150% of the rate of the detergent-free control. There was no effect on 
the “spontaneous” rate. Sodium chloride has an inhibitory effect on urokinase 
and HeLa and HTC plasminogen activators, but below 250 mM no effect was 
observed on plasmin activity (data not shown). Thus 200 mM NaCl was 
added to the plasmin assay solution, which depressed plasminogen activation 
78%. FIGURE 1 presents the time- and plasmin concentrationdependence of 
the reaction. The rates are linear at least two hours if the substrate is not 
depleted. Under these conditions K, is 19 p M ,  k,,, is 45 sec-1. 
Several modifications of the standard procedure were attempted in search 
of increased sensitivity (TABLE 2). The rate with 4,4‘-dithiodipyridine was 
comparable to that with DTNB but the control (zero plasmin) absorbance 
was four-fold higher, thus limiting its utility at low enzyme levels. Doubling 
the substrates produced a 10% sensitivity gain, but with almost double the 
blank value. 
Optimizations of the first step in the reaction (plasminogen activation) 
were performed by coupling these experiments to optimal plasmin assay condi- 
tions. Sodium glycinate gave the highest urokinase activity (TABLE 1). There 
was no effect of glycine concentration (20-1600 mM) on urokinase rate nor 
any effect of Triton X-100 above that attributable to its effect on plasmin 
(data not shown). FIGURE 2 presents the time- and urokinase concentration- 
dependence of the reaction. Urokinase activity is not reproducibly linear 
beyond 45 min, even in the absence of substrate depletion. 
A direct comparison was made to a sensitive [1Z51]fibrin-lysis assay using 
either a continuous or discontinuous procedure (FIGURE 3). In the discon- 
620 Annals New York Academy of Sciences 
tinuous assays, whether spectrophotometric or radiometric, the rate is directly 
proportional to the urokinase concentration, thus upward curvature would be 
expected on semi-log graph paper. In the continuous assays, both proteases 
are acting simultaneously (two amplifying mechanisms), thus, based on an 
analysis of the kinetic equations the response presented on semi-log paper 
should be linear. I t  is obvious that the spectrophotometric assay is significantly 
more sensitive than the radiometric assay. 
The standard assay was used to evaluate K,,, and k,,, for the urokinase- 
catalyzed activation of plasminogen. K,,, and k,,, values were 1.7 pM and 
TABLE 1 
EFFECTS OF VARIOUS BUFFERS ON PLASMIN AND 
UROKINASE ACTIVITY * 
Relative Rates of Hydrolysis 
(% of Rate in Sodium 
Phosphate ) 
Plasmin Urokinase 
Buffer Enzymic Non-enzymic Enzymic 
Phosphate (Na) 100 100 100 
MOPS t 92 100 118 
Barbital t 93 250 - 
Tris t 76 420 102 
Glycine f 79 220 143 
Triethanolamine -i 87 290 100 
Tricine i 86 290 104 
Pyrophosphate t 75 120 69 
Phosphate ( K )  t 82 - 100 
HEPES * 84 - 126 
TESt 92 - 116 
* All assays were performed at 37" C. Plasmin activity was determined by con- 
tinuous recording of A,,?. Urokinase activity was determined by the standard 
plasminogen activation assay described herein. In each case the pH profile (6.5-10) 
for sodium phosphate was obtained for comparison. The pH optima were: plasmin, 
7.5; urokinase, 8.5-9.0. There was no variation in the blank rate in the urokinase 
assay. All buffers are 100 mM. pH was measured before and after incubation, and 
these values agreed 2 0.05. 
t pH 8.50. 
t pH 7.50. 
44 min-l, respectively, in 0.15 M NaCI. These compare favorably with 1.7 pM 
and 50 min-1 reported by Wohl et al." for the high molecular weight form of 
urokinase at pH 7.40, 37" C. The K,,, of the HeLa plasminogen activator was 
1.8 p M ;  Vm2 was 0.16 ng plasminogen activated/min/ng HeLa protein. 
Inhibition of urokinase activity by Phe.Ala.ArgCH,Cl (FIGURE 4) and the 
dexamethasone-induced inhibitor from HTC cells (FIGURE 5)  was also analyzed. 
The bimolecular rate constants (k , , , / [ I ] )  for the inactivation of urokinase by 
the chloromethyl ketone, whether determined by the coupled plasminogen- 
activation assay or by the direct urokinase-catalyzed hydrolysis of Z-Lys-SBzl 
(26 X lo3 and 24 x 103 min-I.M-l, respectively), are in close agreement. 
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FIGURE 1. The time- and plasmin concentration-dependence of Z-Lys-SBzl hy- 
drolysis. A. Reactions were stopped at the time indicated by addition of soybean trypsin 
inhibitor. Reaction volume was 1.0 ml. [Z-Lys-SBzl] = 200 p M ,  [DTNB] = 220 
&f. Plasmin concentrations were 0.1 (O), 0.3 (01, 0.5 (U), and 0.8 (0 )  nM. 
B. Conditions were as stated in FIGURE 1A. The reactions were stopped at 20 (O), 
40 (O),  60 (U), 90 (a), and 120 (A) min. The lines were determined by linear- 
regression fit of the data and are drawn to encompass only the linear portion of 
the data. All data points represent the average of duplicates. 
TABLE 2
VARIATIONS ON THE STANDARD PLASMIN-CATALYZED HYDROLYSIS OF
Z-LYS-SBZL COUPLED WITH DTNB * 
Substrate/Chromogen Sensitivity (A/nM) 
Z-Lys-SBzl/DTNB 2000 
Z-Lys-SBzl/2,2'-dithiodipyridine f 700 
Z-Lys-SBzl/DTNB (2X) t 2260 
Z-Lys-SBzl/4,4'-dithiodipyridine 5 2030 
D-Val.Leu.Lys p-nitroanilide '1 600 
* Plasmin was varied 0-1 nM in 60 min assays that were terminated by addition 
of 100 pl soybean trypsin inhibitor as detailed in the Experimental section. DTNB 
reactions were measured at 412 nm. 
t Both reagents were at twice the standard concentrations. 
t Measured at 270 nm, the wavelength of maximum AA. 
8 Measured at 324 nm, the wavelength of maximum AA. 
















FIGURE 2. The time- and urokinase concentration-dependence of the plasminogen 
activation reaction coupled to the hydrolysis of Z-Lys-SBzl by plasmin. The con- 
ditions for the thiol ester hydrolysis are described in the Experimental section. A. The 
reaction was terminated at the indicated time by addition of 950 pl of the plasmin 
reaction solution as described in the text. Urokinase concentrations were 1.08 (01, 
2.7 (0). 5.4 (B), and 10.8 (0) pM. B. Conditions were as described in FIGURE 
2A. The activations were quenched at I5 (O), 30 ( O ) ,  and 45 (m) min. Data at 
60 and 75 min are not presented since the response is not a linear function beyond 
45 min (see FIGURE 2A). All times and concentrations relate to the 50 pl activation 
reaction. The lines represent a linear-regression lit of the data and are drawn to 
encompass only the linear portion of the data. All data points represent the 
average of duplicates. 
These results differ significantly from those of Kettner and Shaw,l6 2.9 x lo3 
min-l-M-l, however the pH used here was 1.5 units more basic, which could 
account for a higher rate. Scatchard analysis of the inhibition of urokinase by 
the dexarnethasone-induced inhibitor from HTC cells yields Ki  - 1 0-l2 M, but 
the stoichiornetry cannot be calculated because the concentration of inhibitor 
is unknown. A K ,  in this range has been previously reported by Green 18 for 
the association of Kunitz pancreatic inhibitor (aprotinin) with bovine trypsin, 
but most protease-inhibitor complexes have lower affinities. 
DISCUSSION 
In general base-catalyzed reactions, such as the “spontaneous” hydrolysis of 
Z-Lys-SBzI, the choice of buffering agent is often critical if the assay is to be 
used near its limit of sensitivity. The small list of buffers tested here includes a 
wide range of “spontaneous” rates and suggests the utility of buffer surveys as 
a general procedure in assay development. 
The standard assay employs 1.0 pM plasminogen which is close to the K,,, 
concentration. An approximately two-fold increase in sensitivity would be 
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realized if a ten-fold higher plasminogen concentration were used, but in most 
cases the higher sensitivity is not needed, and the use of 10 pM or higher 
substrate would consume large amounts of plasminogen. 
Since there are no pure inhibitors available that are completely selective 
for plasminogen activators in the presence of plasmin, several other methods 
were used to depress the activation during the Z-Lys-SBzl step. Primarily, 
plasminogen activation was inhibited by dilution (20-fold), but the pH shift 
(1 unit off the optimum) and the addition of shloride yielded substantial 
additional inhibition (two- and three-fold, respectively). The net activator 
activity in the second step was less than 1 % of its initial value. 
The sensitivity with the thiol ester compares favorably with the other sub- 
strates tested. As an ester, 2-LysSBzl has the advantage of the lowest K,, and 
highest k,,,. Most of the amide substrates have high K,,, and low k,,, values. 
Their chief advantage is their chemical stability. Fluorogenic amide substrates 
might yield a more sensitive assay based on the greater sensitivity of detection. 
Were a fluorogenic thiol reagent substituted for DTNB the limit of detection 
of the hydrolysis of Z-Lys-SBzl might be lowered. 
The spectrophotometric assay is considerably more sensitive than the radio- 
4 I .  / /  
4 6 8 1 0  20 4060100 200 
" 
Urokinase Activity (moles x 10'7) 
FIGURE 3. A comparison of spectrophotometric and radiometric coupled assays 
for urokinase. The spectrophotometric assay (0) was performed according to the 
standard procedures outlined in the text. The volume of continuous radiometric 
assay is 1.0 ml in 100 mM sodium glycinate, pH 8.50 with 50 nM plasminogen. 
Total CPM released at 60 (0 )  and 105 (M) min of incubation are presented. The 
latter time is the total time required by the discontinuous assays. In the discon- 
tinuous radiometric assay (0) plasminogen (1.0 p M )  was activated by urokinase 
in the glycine buffer for 45 min then a 50 pl aliquot was added to the YIIfibrin- 
coated well containing 950 pl of 200 mM sodium phosphate and 200 mM NaCI. 
Total CPM released after 60 min in the presence of fibrin are presented. All reac- 
tions were perfomed at 37" C. All radiometric points are averages of triplicates. 
All spectrophotometric points are averages of duplicates. 
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metric assay. In the direct comparison (FIGURE 3) there is no difference 
between 2.7 and 13.5 X 1@li moles by the radiometric assay, whereas AA,,, 
is 0.50 between 5.4 and 13.5 X moles. Typically in the Z-Lys-SBzl assay 
the measured difference between 2.7 X lo-" moles urokinase and the zero 
urokinase control is >0.100 A,,,. The assay is also sensitive to other plasmino- 
gen activators. 1 ng of protein from HeLa serum-free conditioned medium 
yields net AA,,, = 0.190. For 1 pg of protein from HTC whole-cell extract 
the net A A ~ , :  =0.54. 20 ng of serum-free conditioned medium protein from 
dexamethasone-induced HTC cells inhibits 90% of the activity present in 
7 X lO-1fi moles of urokinase. 
The wide versatility of the method is demonstrated by the ease of determina- 
tion of K, and V, values for plasminogen activation and of inhibition con- 
stants for the interaction of the enzyme with natural or synthetic inhibitors. 
Since the assay is more rapid and sensitive to low levels of enzyme it is more 
readily adaptable to monitoring enzyme purification than [lZSI]fibrinolysis. 
In summary, the procedure is a sensitive, precise, and rapid method for the 
analysis and characterization of plasminogen activators. All reagents and 
materials are inexpensive and commercially available, the colored products are 
stable, and the measurement is performed on the standard quality spectro- 
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FIGURE 4. The inactivation of urokinase by Phe.Ala.ArgCHE1. Prior to activity 
determination by the standard assay, urokinase (1.08 x M )  was incubated with 
the indicated concentration of the tripeptidyl inhibitor in 80 mM sodium glycinate, 
pH 8.50 with 1 mg/ml bovine serum albumin, 25" C. At the indicated times, 
5 pl of the reaction solution were diluted into 85 pl of the same glycine buffer at 
0". At the completion of the inactivation reaction (8 min) all activation reactions 
were initiated simultaneously by addition of 10 pl of 10 pM plasminogen and 
removal to a 37" C incubator. 900 pl rather than 950 pl of plasmin reaction 
solution was used. k.,, /[ l]  = 260 x 1oL min-'-M-'. 
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FIGURE 5. Scatchard analysis of the inhibition of urokinase by the plasminogen- 
activator inhibitor from hepatoma tissue-culture cells. The inhibitor test solution 
was the serum-free conditioned medium from dexamethasone-induced (lo-' M, 16 h) 
cells. 1-5 pl of test solution were incubated with urokinase (2.7 x lo-" moles) for 15 
min at 25" in 45 pl total volume. The activation reaction was started by the addition 
of 5pl of 10 pM plasminogen and shifted to 37" C. E is the concentration of active 
urokinase; r is the. concentration of inactive urokinase. 
photometer available in almost all laboratories. It is superior to existing 
methods in its simplicity and ease of manipulation and in the quality of the 
resultant data-kinetic constants rather than arbitrary units. 
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